US FDA Looks To Assure Advisory Committees' Subject Expertise With More Temporary Members

Expect More Temporary Members Voting In US FDA Advisory Committees

Reform efforts in CDER include ensuring expertise is specific to the issues being discussed, which may mean more temporary voting members on advisory committees.

CDER Director Patrizia Cavazzoni, left, speaks with Cardinal Health's Assistant General Counsel Sonali Gunawardhana during an 18 May FDLI Annual Conference session.
CDER Director Patrizia Cavazzoni, left, speaks with Cardinal Health assistant general counsel Sonali Gunawardhana on 18 May during FDLI conference session. • Source: FDLI

Advisory committee reform for the US Food and Drug Administration’s Center for Drug Evaluation and Research includes product-specific adjustments to the group offering advice.

CDER Director Patrizia Cavazzoni expects more temporary members could be added to advisory committees going forward to ensure the groups’...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Rx-to-OTC Switch

More from Health